Immunosuppressive medication has been both a boon and a bane to transplant patients since the first organ transplant was performed. Transplantation was usually only possible due to immunosuppressive drugs such as cyclosporine, which allowed patients to receive an organ with much lower risk of rejection. However, these medications can have side effects such as high blood sugar, osteoporosis, decreased muscle function and other problems.
In this short video clip, Dr. Joseph Leventhal touches on the Northwestern Comprehensive Transplant Center’s work to greatly lessen or end the need for immunosuppression in transplant patients.
Click here for more information about Northwestern’s research on immune tolerance and other issues in transplant medicine.Donate to Northwestern Memorial Foundation